Renown Health
7
2
4
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
14.3%
1 terminated/withdrawn out of 7 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Helix Research Network
Role: collaborator
Assessing PFAS Exposure (APEX) for Better Health
Role: collaborator
A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals
Role: collaborator
Supporting Treatment Resilience With Optimized Nutrition and Guided Exercise in Head and Neck Cancer Patients Undergoing Chemoradiation
Role: lead
Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19
Role: collaborator
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
Role: collaborator
AIRVO Device Intervention for Moderate to Severe COPD
Role: lead
All 7 trials loaded